Nutriband (NTRB) to Release Quarterly Earnings on Friday

Nutriband (NASDAQ:NTRB - Get Free Report) is projected to release its earnings data before the market opens on Friday, May 30th. Analysts expect Nutriband to post earnings of ($0.13) per share and revenue of $0.71 million for the quarter.

Nutriband (NASDAQ:NTRB - Get Free Report) last issued its quarterly earnings data on Monday, April 28th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.12) by ($0.06). The company had revenue of $0.64 million for the quarter, compared to analysts' expectations of $0.71 million. Nutriband had a negative return on equity of 54.49% and a negative net margin of 338.51%. On average, analysts expect Nutriband to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Nutriband Price Performance

NTRB stock traded up $0.33 during mid-day trading on Wednesday, reaching $6.31. 69,508 shares of the company traded hands, compared to its average volume of 77,399. The company has a fifty day moving average price of $5.64 and a 200-day moving average price of $5.67. Nutriband has a 52-week low of $3.72 and a 52-week high of $11.78. The company has a market capitalization of $70.38 million, a P/E ratio of -8.89 and a beta of 1.18. The company has a debt-to-equity ratio of 0.01, a current ratio of 4.96 and a quick ratio of 4.83.

About Nutriband

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.